Compare AbCellera Biologics Inc (ABCL) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Paychex, Inc. — how do they compare? AbCellera Biologics Inc trades at $9.13 (market cap $2.99B), while Paychex, Inc. trades at $120.92 (market cap $43.14B). The key difference: Paychex, Inc. is far larger — about 14.4× AbCellera Biologics Inc's market cap, and Paychex, Inc. pays a 3.92% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | PAYX | |
|---|---|---|
Market Cap | $2.99B | $43.14B |
Sector | Health | Industrials |
52-Week High | $9.76 | $140.81 |
52-Week Low | $2.78 | $85.57 |
Enterprise Value | $2.58B | $46.63B |
Dividend Yield | — | 3.92% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
